Brian J. Gates, Pharm.D., Jeffrey A. Clark, Pharm.D., Steven Huang, Pharm.D.
Historically, geriatric adults with diabetes have been given similar treatment goals as younger adults. However, there is increasing recognition that geriatric patients differ from younger patients, and there are important differences even within the geriatric population. Therefore, it is critical for health-care professionals to understand changes associated with aging and how these can impact diabetes treatment in order to best individualize care.
Diabetes in specific populations — Geriatric
Gretchen I. Riker, Pharm,D., C.G.P.
Polypharmacy is a growing problem seen in medicine today, and most factors suggest that this trend is likely to continue. “Deprescribing” is a term that has been coined as a potential treatment for this problem. This article will explore what polypharmacy is and how the problem can be decreased through prevention and treatment.
November is National Diabetes Month. We should seize this time as an opportunity not only to increase awareness about diabetes, but to encourage screening for undiagnosed diabetes, which represents at least one-third of all people with diabetes mellitus in the United States. The challenge will be to identify the population to be screened, and then to develop innovative strategies to screen individuals who would not normally attend traditional screening opportunities such as clinic visits or health fairs.